BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21673857)

  • 21. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
    Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
    Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pricing and availability of some essential child specific medicines in Odisha.
    Swain TR; Rath B; Dehury S; Tarai A; Das P; Samal R; Samal S; Nayak H
    Indian J Pharmacol; 2015; 47(5):496-501. PubMed ID: 26600637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Availability, accessibility, and affordability of neurodiagnostic tests in 37 countries.
    McLane HC; Berkowitz AL; Patenaude BN; McKenzie ED; Wolper E; Wahlster S; Fink G; Mateen FJ
    Neurology; 2015 Nov; 85(18):1614-22. PubMed ID: 26446063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
    ; Hanson K; Goodman C
    Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of private and public ambulatory health care in low and middle income countries: systematic review of comparative studies.
    Berendes S; Heywood P; Oliver S; Garner P
    PLoS Med; 2011 Apr; 8(4):e1000433. PubMed ID: 21532746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization and expenditure at public and private facilities in 39 low-income countries.
    Saksena P; Xu K; Elovainio R; Perrot J
    Trop Med Int Health; 2012 Jan; 17(1):23-35. PubMed ID: 22008480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicine prices and availability in the Brazilian Popular Pharmacy Program.
    Pinto Cdu B; Miranda ES; Emmerick IC; Costa Ndo R; Castro CG
    Rev Saude Publica; 2010 Aug; 44(4):611-9. PubMed ID: 20585741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. District decision-making for health in low-income settings: a case study of the potential of public and private sector data in India and Ethiopia.
    Bhattacharyya S; Berhanu D; Taddesse N; Srivastava A; Wickremasinghe D; Schellenberg J; Iqbal Avan B
    Health Policy Plan; 2016 Sep; 31 Suppl 2(Suppl 2):ii25-ii34. PubMed ID: 27591203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying a Total Market Lens: Increased IUD Service Delivery Through Complementary Public- and Private-Sector Interventions in 4 Countries.
    White JN; Corker J
    Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S21-32. PubMed ID: 27540122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
    Dong Z; Tao Q; Yan B; Sun G
    PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical resources in South Africa: an analysis of the inequalities between the public and private sector.
    Dell AJ; Klopper J
    S Afr J Surg; 2018 Jun; 56(2):16-20. PubMed ID: 30010259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.
    van Mourik MS; Cameron A; Ewen M; Laing RO
    BMC Cardiovasc Disord; 2010 Jun; 10():25. PubMed ID: 20534118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries.
    Cameron A; Bansal A; Dua T; Hill SR; Moshe SL; Mantel-Teeuwisse AK; Saxena S
    Epilepsia; 2012 Jun; 53(6):962-9. PubMed ID: 22432967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Availability of Access, Watch, and Reserve groups of essential antibiotics: a cross-sectional survey.
    Rafi S; Anjum SM; Usman M; Nawaz HA; Chaudhry M; Babar ZU; Rasheed H
    Front Public Health; 2023; 11():1251434. PubMed ID: 38239798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Availability of generic drugs in the public sector and prices in the private sector in different regions of Brazil].
    Miranda ES; Pinto Cdu B; dos Reis AL; Emmerick IC; Campos MR; Luiza VL; Osorio-de-Castro CG
    Cad Saude Publica; 2009 Oct; 25(10):2147-58. PubMed ID: 19851615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis.
    Armstrong-Hough M; Sharma S; Kishore SP; Akiteng AR; Schwartz JI
    PLoS One; 2020; 15(12):e0241555. PubMed ID: 33362249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-diabetic drugs in the private and public sector in Dar es Salaam, Tanzania.
    Justin-Temu M; Nondo RS; Wiedenmayer K; Ramaiya KL; Teuscher A
    East Afr Med J; 2009 Mar; 86(3):110-4. PubMed ID: 19702097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.